Cargando…

Key population-led community-based same-day antiretroviral therapy (CB-SDART) initiation hub in Bangkok, Thailand: a protocol for a hybrid type 3 implementation trial

BACKGROUND: Same-day antiretroviral therapy (SDART) initiation, in which people living with HIV (PLHIV) who are antiretroviral therapy (ART)-naïve, willing, and clinically eligible start ART on the same day of HIV diagnosis, has been implemented in several healthcare facilities in Thailand since 201...

Descripción completa

Detalles Bibliográficos
Autores principales: Lujintanon, Sita, Amatavete, Sorawit, Thitipatarakorn, Supanat, Puthanakit, Thanyawee, Songtaweesin, Wipaporn Natalie, Chaisalee, Tanachai, Janyam, Surang, Phanuphak, Nittaya, Ramautarsing, Reshmie A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526529/
https://www.ncbi.nlm.nih.gov/pubmed/36183120
http://dx.doi.org/10.1186/s43058-022-00352-9
_version_ 1784800895198822400
author Lujintanon, Sita
Amatavete, Sorawit
Thitipatarakorn, Supanat
Puthanakit, Thanyawee
Songtaweesin, Wipaporn Natalie
Chaisalee, Tanachai
Janyam, Surang
Phanuphak, Nittaya
Ramautarsing, Reshmie A.
author_facet Lujintanon, Sita
Amatavete, Sorawit
Thitipatarakorn, Supanat
Puthanakit, Thanyawee
Songtaweesin, Wipaporn Natalie
Chaisalee, Tanachai
Janyam, Surang
Phanuphak, Nittaya
Ramautarsing, Reshmie A.
author_sort Lujintanon, Sita
collection PubMed
description BACKGROUND: Same-day antiretroviral therapy (SDART) initiation, in which people living with HIV (PLHIV) who are antiretroviral therapy (ART)-naïve, willing, and clinically eligible start ART on the same day of HIV diagnosis, has been implemented in several healthcare facilities in Thailand since 2017. This evidence-based practice has demonstrated increased ART uptake, virologic suppression, and retention in care. However, linkage to care gaps exist in community-based organizations (CBOs) in Bangkok whereby as much as 20% of key populations (KP), mainly men who have sex with men and transgender women, living with HIV were lost to follow-up pre-ART initiation. To increase access to and uptake of ART among these populations, this study proposes that trained KP lay providers should lead community-based ART (CB-SDART) initiation service. This protocol describes the combined use of the Proctor’s implementation outcome framework and the Consolidated Framework for Implementation Research to guide and evaluate the CB-SDART implementation. METHODS: This study follows the hybrid design type 3: it is an implementation trial that secondarily assesses service and client outcomes by comparative interrupted time series analysis. Five strategies have been formulated to meet three implementation outcomes (i.e., feasibility, fidelity, and sustainability): (1) developing stakeholder relationships by engaging the CBO leaderships, (2) training and educating KP lay providers, (3) adapting and tailoring SDART to CBO-specific context, (4) using evaluative and iterative strategies to assess adherence to standard operating procedures, and (5) developing stakeholder relationships by engaging external stakeholders. Teleconsultation with physicians and ART home delivery will be integrated as another ART initiation option for clients and allow service provision during the COVID-19 pandemic. A mixed-method assessment will be conducted on key stakeholders and PLHIV diagnosed at two implementing CBOs, Rainbow Sky Association of Thailand and Service Workers in Group Foundation, in Bangkok, Thailand. DISCUSSION: This implementation research may be the first to provide robust data at the implementation, service, and client levels to inform how to successfully task-shift SDART initiation service to trained KP lay providers and facilitate the expansion of CB-SDART in the future. TRIAL REGISTRATION: This trial was registered with the Thai Clinical Trial Registry as TCTR20210709004 on July 9, 2021. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s43058-022-00352-9.
format Online
Article
Text
id pubmed-9526529
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-95265292022-10-03 Key population-led community-based same-day antiretroviral therapy (CB-SDART) initiation hub in Bangkok, Thailand: a protocol for a hybrid type 3 implementation trial Lujintanon, Sita Amatavete, Sorawit Thitipatarakorn, Supanat Puthanakit, Thanyawee Songtaweesin, Wipaporn Natalie Chaisalee, Tanachai Janyam, Surang Phanuphak, Nittaya Ramautarsing, Reshmie A. Implement Sci Commun Study Protocol BACKGROUND: Same-day antiretroviral therapy (SDART) initiation, in which people living with HIV (PLHIV) who are antiretroviral therapy (ART)-naïve, willing, and clinically eligible start ART on the same day of HIV diagnosis, has been implemented in several healthcare facilities in Thailand since 2017. This evidence-based practice has demonstrated increased ART uptake, virologic suppression, and retention in care. However, linkage to care gaps exist in community-based organizations (CBOs) in Bangkok whereby as much as 20% of key populations (KP), mainly men who have sex with men and transgender women, living with HIV were lost to follow-up pre-ART initiation. To increase access to and uptake of ART among these populations, this study proposes that trained KP lay providers should lead community-based ART (CB-SDART) initiation service. This protocol describes the combined use of the Proctor’s implementation outcome framework and the Consolidated Framework for Implementation Research to guide and evaluate the CB-SDART implementation. METHODS: This study follows the hybrid design type 3: it is an implementation trial that secondarily assesses service and client outcomes by comparative interrupted time series analysis. Five strategies have been formulated to meet three implementation outcomes (i.e., feasibility, fidelity, and sustainability): (1) developing stakeholder relationships by engaging the CBO leaderships, (2) training and educating KP lay providers, (3) adapting and tailoring SDART to CBO-specific context, (4) using evaluative and iterative strategies to assess adherence to standard operating procedures, and (5) developing stakeholder relationships by engaging external stakeholders. Teleconsultation with physicians and ART home delivery will be integrated as another ART initiation option for clients and allow service provision during the COVID-19 pandemic. A mixed-method assessment will be conducted on key stakeholders and PLHIV diagnosed at two implementing CBOs, Rainbow Sky Association of Thailand and Service Workers in Group Foundation, in Bangkok, Thailand. DISCUSSION: This implementation research may be the first to provide robust data at the implementation, service, and client levels to inform how to successfully task-shift SDART initiation service to trained KP lay providers and facilitate the expansion of CB-SDART in the future. TRIAL REGISTRATION: This trial was registered with the Thai Clinical Trial Registry as TCTR20210709004 on July 9, 2021. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s43058-022-00352-9. BioMed Central 2022-10-01 /pmc/articles/PMC9526529/ /pubmed/36183120 http://dx.doi.org/10.1186/s43058-022-00352-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Study Protocol
Lujintanon, Sita
Amatavete, Sorawit
Thitipatarakorn, Supanat
Puthanakit, Thanyawee
Songtaweesin, Wipaporn Natalie
Chaisalee, Tanachai
Janyam, Surang
Phanuphak, Nittaya
Ramautarsing, Reshmie A.
Key population-led community-based same-day antiretroviral therapy (CB-SDART) initiation hub in Bangkok, Thailand: a protocol for a hybrid type 3 implementation trial
title Key population-led community-based same-day antiretroviral therapy (CB-SDART) initiation hub in Bangkok, Thailand: a protocol for a hybrid type 3 implementation trial
title_full Key population-led community-based same-day antiretroviral therapy (CB-SDART) initiation hub in Bangkok, Thailand: a protocol for a hybrid type 3 implementation trial
title_fullStr Key population-led community-based same-day antiretroviral therapy (CB-SDART) initiation hub in Bangkok, Thailand: a protocol for a hybrid type 3 implementation trial
title_full_unstemmed Key population-led community-based same-day antiretroviral therapy (CB-SDART) initiation hub in Bangkok, Thailand: a protocol for a hybrid type 3 implementation trial
title_short Key population-led community-based same-day antiretroviral therapy (CB-SDART) initiation hub in Bangkok, Thailand: a protocol for a hybrid type 3 implementation trial
title_sort key population-led community-based same-day antiretroviral therapy (cb-sdart) initiation hub in bangkok, thailand: a protocol for a hybrid type 3 implementation trial
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526529/
https://www.ncbi.nlm.nih.gov/pubmed/36183120
http://dx.doi.org/10.1186/s43058-022-00352-9
work_keys_str_mv AT lujintanonsita keypopulationledcommunitybasedsamedayantiretroviraltherapycbsdartinitiationhubinbangkokthailandaprotocolforahybridtype3implementationtrial
AT amatavetesorawit keypopulationledcommunitybasedsamedayantiretroviraltherapycbsdartinitiationhubinbangkokthailandaprotocolforahybridtype3implementationtrial
AT thitipatarakornsupanat keypopulationledcommunitybasedsamedayantiretroviraltherapycbsdartinitiationhubinbangkokthailandaprotocolforahybridtype3implementationtrial
AT puthanakitthanyawee keypopulationledcommunitybasedsamedayantiretroviraltherapycbsdartinitiationhubinbangkokthailandaprotocolforahybridtype3implementationtrial
AT songtaweesinwipapornnatalie keypopulationledcommunitybasedsamedayantiretroviraltherapycbsdartinitiationhubinbangkokthailandaprotocolforahybridtype3implementationtrial
AT chaisaleetanachai keypopulationledcommunitybasedsamedayantiretroviraltherapycbsdartinitiationhubinbangkokthailandaprotocolforahybridtype3implementationtrial
AT janyamsurang keypopulationledcommunitybasedsamedayantiretroviraltherapycbsdartinitiationhubinbangkokthailandaprotocolforahybridtype3implementationtrial
AT phanuphaknittaya keypopulationledcommunitybasedsamedayantiretroviraltherapycbsdartinitiationhubinbangkokthailandaprotocolforahybridtype3implementationtrial
AT ramautarsingreshmiea keypopulationledcommunitybasedsamedayantiretroviraltherapycbsdartinitiationhubinbangkokthailandaprotocolforahybridtype3implementationtrial